Forbes Daily: Nvidia Tops Expectations Amid Wall Street’s AI Concerns [Forbes]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Forbes
Novo Nordisk pioneered the market for weight loss drugs . Now, amid increasing competition in the space, it's of the next-generation of GLP-1 injectables. The company said Wednesday that it's partnering with Boston biotech startup Vivtex to develop oral versions of Ozempic's successors. The stakes are high: Wall Street expects Novo to lose its market lead to Eli Lilly by the end of the year, and its stock is down 27% so far in 2026. The market still has massive potential: Analyst firm Jefferies predicts up to 40 million Americans will be taking GLP-1s by the end of the decade. This is a published version of the Forbes Daily newsletter , you can sign-up to get Forbes Daily in your inbox FIRST UP Nvidia revenue, an announcement that comes as Wall Street has appeared skeptical about AI in recent weeks. Despite what they called “insatiable” demand for computing power, Cantor Fitzgerald economists said last week that concerns about AI spending remain. The in three weeks, as th
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Novo Nordisk Cuts Wegovy Prices in Half While Its Stock Sits Near a 52-Week Low [Yahoo! Finance]Yahoo! Finance
- Forget Altimmune: This Proven Obesity-Drug Giant Is the Better Weight-Loss Play [Yahoo! Finance]Yahoo! Finance
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVOPR Newswire
- PatentVest Releases New Report on The Oral Small-Molecule GLP-1 Patent Race [Yahoo! Finance]Yahoo! Finance
- Lilly's GLP-1 pill tops Novo's Rybelsus in head-to-head trial [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 2/3/26 - Beat
NVO
Sec Filings
- 2/23/26 - Form 6-K
- 2/23/26 - Form 6-K
- 2/20/26 - Form 6-K
- NVO's page on the SEC website